Latest Market News

Jul 27
Preview of the FOMC Meeting: Hints on Interest Rate Path in 4Q Could be the Key Thing to Watch

Greenback index continues to consolidate in a tight range on Wednesday in the run-up to the FOMC meeting. The range has been forming for about a week and indicates short-term equilibrium in USD supply and demand before the release of key market information. The presence of the pattern suggests that a breakout on Fed information […]

Jul 27
Micro Gold Futures (MGC), H4 Potential For Bearish Drop

Type: Bearish Momentum Key Levels:Resistance: 1738.4Pivot: 1721.8Support: 1678.5 Preferred Case:On the H4, with price moving within a descending channel and RSI moving along a descending trendline, we have a bearish bias that price will drop from the pivot at 1721.8 where the pullback resistance is to 1st support at 1678.5 in line with swing low […]

Jul 27
Silver Wave Analysis – 27 July, 2022

• Silver reversed from support level 18.30 • Likely to rise to resistance level 18.90 Silver earlier reversed up from the pivotal support level 18.30 (which has been steadily reversing the price from the end of June). The upward reversal from the support level 18.30 created the daily Bullish Engulfing – which stopped the earlier […]

Jul 27
AUDNZD Wave Analysis – 27 July, 2022

• AUDNZD broke resistance level 1.1100 • Likely to rise to resistance level 1.1165 AUDNZD recently broke the key resistance level 1.1100 (which has been steadily reversing the pair from the end of June). The breakout of the resistance level 1.1100 continues the active intermediate impulse wave (C) from the middle of July. Given the […]

Jul 27
House passes cannabis research measure

The U.S. House of Representatives late Tuesday passed the Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454) by a vote of 325 to 95. Introduced on July 21 by Reps. Earl Blumenauer – a Democrat from Oregon, and Andy Harris, a Republican from Maryland – the measure resembles Senate Bill 253 passed by the […]

Jul 27
Pfizer and BioNTech launch study to evaluate COVID-19 vaccine targeting original virus strain plus omicron variant

Pfizer Inc. PFE, +1.02% and German partner BioNTech SE BNTX, -1.63% said Wednesday they have started a Phase 2 study to evaluate an enhanced COVID-19 vaccine aimed at the original strain of the virus and the omicron variant that seeks to create a more robust and longer-lasting immune response. The new bivalent vaccine called BNT162b5 […]